ABSTRACT Background Guanxinshutong capsule (GXST), derived from Mongolian medicine, is widely used for coronary heart disease. However, the influence of gut microbiota on the bioavailability of its major components remains unknown. This study compared the impact of gut microbiota on the pharmacokinetics of GXST's major components. Methods Plasma samples were collected from normal and broad‐spectrum antibiotic (ABX)‐pretreated rats after oral GXST administration. An ultrahigh performance liquid chromatography‐mass spectrometry (UHPLC–MS) method was established and validated (specificity, stability, recovery, and matrix effect) to quantify nine major components. Pharmacokinetic parameters were fitted using a non‐compartmental model. Results The validated UHPLC–MS method met analytical criteria. Gut microbiota notably influenced the bioavailability of ellagic acid, ferulic acid, salvianolic acid B, tricin, cryptotanshinone, and tanshinone IIA. Relative bioavailabilities (normal/ABX‐pretreated) were ellagic acid 69.9%, ferulic acid 38.3%, salvianolic acid B 44.3%, tricin 51.6%, cryptotanshinone 144.2%, and tanshinone IIA 81.6%. Notably, the relative bioavailabilities of ferulic acid, salvianolic acid B, and tricin were reduced by approximately 50%. Conclusions A sensitive UHPLC–MS method for simultaneous quantification of nine GXST components in rat plasma was validated. These findings provide new insights for pharmacokinetic studies of Traditional Chinese Medicine (TCM) and natural products.
Yihang Lu, Xiaoya Wang, Xinmeng Wang, Yu He, Jiehong Yang, Chang Li et al. Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats. // Phytochemical Analysis. – 2026. – DOI: 10.1002/pca.70097. – URL: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/pca.70097?af=R
Yihang Lu, Xiaoya Wang, Xinmeng Wang, Yu He, Jiehong Yang, Chang Li, & Haitong Wan (2026). Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats. Phytochemical Analysis. https://doi.org/10.1002/pca.70097
Yihang Lu, et al. “Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats.” Phytochemical Analysis, 2026. doi:10.1002/pca.70097.
@article{Lu2026,
title = {Effects of Gut Microbiota Modulation on the Oral Pharmacokinetics of Major Components From Guanxinshutong Capsules in Rats},
author = {Lu, Yihang and Wang, Xiaoya and Wang, Xinmeng and He, Yu and Yang, Jiehong and Li, Chang and Wan, Haitong},
journal = {Phytochemical Analysis},
year = {2026},
doi = {10.1002/pca.70097},
url = {https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/pca.70097?af=R}
}
ABSTRACT Aim of the Study Integrating metabolomics, network pharmacology, and zebrafish depression models, this study explored the pharmacodynamic material basis and potential quality markers (Q‐markers) of Yueju Wan (YJW) against...
ABSTRACT Introduction As one of the most common chronic liver diseases worldwide, metabolic dysfunction‐associated steatotic liver disease (MASLD) imposes an escalating burden on global health systems. However, the efficacy of Guizhi...
ABSTRACT Introduction Colorectal cancer (CRC) remains one of the leading causes of cancer‐related mortality worldwide. Combination therapies, which integrate traditional Chinese medicine (TCM) with conventional chemotherapeutic agents,...
ABSTRACT Introduction In‐depth profiling of plant‐derived metabolites is essential for unraveling chemically diverse group of bioactive compounds that play essential roles in plant defense, adaptation, ecological interactions, and human...
ABSTRACT Objective This study aims to systematically evaluate the in vitro stability and pharmacokinetic behavior of representative polyphenols in Qingzhuan dark tea (QDT) and to explore the relationship between physicochemical...